Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Reexamination Certificate
2005-11-08
2005-11-08
Mosher, Mary E. (Department: 1648)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
C424S094670, C424S832000, C514S002600, C530S388220, C530S391700, C530S350000, C530S402000, C435S069100, C435S069700, C435S220000
Reexamination Certificate
active
06962703
ABSTRACT:
The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neutron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
REFERENCES:
patent: 5668255 (1997-09-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6395513 (2002-05-01), Foster et al.
patent: WO 91/09871 (1991-07-01), None
patent: WO 92/15327 (1992-09-01), None
patent: WO 93/04191 (1993-03-01), None
patent: WO 93/15766 (1993-08-01), None
patent: WO 94/21300 (1994-09-01), None
patent: WO 96/12802 (1996-05-01), None
Dodd J et al. Journal of neuroscience. Lactoseries carbohydrates specify subsels of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. Dec. 1985, 5 (12) p3278-94. Abstract only cited.
Molliver D C et al. Journal of comparative neurology. Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics . . . Oct. 23, 1995, 361 (3) p404-16. Abstract only cited.
Chen C C et al. Nature. A P2X purinoceptor expressed by a subset of sensory neurons. Oct. 5, 1995, 377 (6548) p428-31. Abstract only cited.
Konttinen Y T et al. Archives of orthopaedic and trauma surgery. Immunoreactive neuropeptide nerves in ligamentous tissue in chronic shoulder pain. 1992, 111 (6) p341-4. Abstract only cited.
Traub R J et al. Journal of comparative neurology. Analysis of catcitonin gene-related peptide-like immunoreactivity in the cat dorsal spinal cord and dorsal root ganglia . . . Dec. 15, 1990, 302 (3) p562-74. Abstract only cited.
Orozco O E et al. European journal of neuroscience. GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Jun. 2001, 13 (11) p2177-82.
Dong X et al. Cell. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons Sep. 7, 2001, 106 (5) p619-32.
Kim et al., Ribonuclease S-peptide as a carrier in fusion proteins, Protein Science 2(3)(1993) pp. 348-356.
Rock et al., Overexpression and structure-function analysis of a bioengineered IL-2/IL-6 chimeric lymphokine, Protein Engineering, vol. 5 (6):583-91.
O'Hare et al., Cytotoxicity of a recombinant ricin-A-chain fusion protein containing proteolytically-cleavable spacer sequence, FEBS Letters, vol. 273(1-2) pp. 200-204.
Lorberboum-Galaski et al., Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced inEscherichia coli, Proc. Natl. Acad. Sci. USA 85(6): 1922-1926.
John R. Murphy, Diphteria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin development, Cancer Treatment Res: 37:123-140.
Williams et al., Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein, Protein Eng. 1(6)(1987):493-498.
Arora et al., Cytotoxic Effects of a Chimeric Protein consisting of Tetanus Toxin Light Chain and Anthrax Lethal Factor in Non-neuronal Cells, Journal of Biol. Chem: (1994):269(42):26265-71.
Brinkmann et al., A recombinant immunotoxin containing a disulfide-stabilized Fv fragment, Proc. Natl. Acad. Sci. USA (1993): 90(1):7538-42.
Ulrich et al.. “Human beta-nerve growth factor gene sequence highly homologous to that of mouse.” Nature (1983), 303:821-825.
Borsani et al., cDNA sequence of human B-NGF, Nucleuic Acids Res. (1990), 18:4020.
Noda et al., “Isolation and structural organization of the human preproenkephalin gene”, Nature (1982) 297:431-434.
Comb et al., Primary structure of the human Met-and Leu-enkephalin precursor and its mRNA, Nature (1985), 295:663-666.
Takagaki et al., “Cloning and sequence analysis of cDNAs for human high moleuclar weight and low molecular weight prekininogens, Primary structures of two human rekininogens”, J. Biol. Chem. (1985) 260:8601-8609.
Dicou et al., Expression of recombinant human nerve growth factor inEscherichia coli, Neurochem Int. 20, pp. 129-134.
Fujimori et al., Overproduction of biologically-acative human nerve growth factor inEscherichia coli, Biosci-Biotechnol-Biochem, 56, (1992), 1985-1990.
B. Bizzini, Investigation of the Mode of Action of the Tetannus Toxin with the Aid of Hybrid Molecules Consisting in part of Tetanus Toxin-Derived Fragments; Dept. of Protein Immochemistry, Pasteur Institute, Bacterial Protein Toxins, 1984, pp. 427-434.
Duggan Michael John
Foster Keith Alan
Shone Clifford Charles
Health Protection Agency
Ipsen Limited
Mosher Mary E.
LandOfFree
Clostridial toxin derivatives able to modify peripheral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clostridial toxin derivatives able to modify peripheral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clostridial toxin derivatives able to modify peripheral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501616